1. Short-term efficacy of endovascular procedures for lower extremity thromboangiitis obliterans (Buerger’s disease)
   Guofu Zheng et al, 2024, Postgraduate Medicine CrossRef
2. Levistilide A Ameliorates NLRP3 Expression Involving the Syk-p38/JNK Pathway and Peripheral Obliterans in Rats
   Huining Guo et al, 2018, Mediators of Inflammation CrossRef
3. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways
   Chongchong Zou et al, 2022, Frontiers in Pharmacology CrossRef
4. Risk Factors, Mechanisms and Treatments of Thromboangiitis Obliterans: An Overview of Recent Research
   Meng-di Li et al, 2020, Current Medicinal Chemistry CrossRef